ReviewAdvances in immunology2002
Proteolysis and antigen presentation by MHC class II molecules.
Review in Advances in immunology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- The Atlantic Cod MHC I compartment has the properties needed for cross-presentation in the absence of MHC II.Scientific reports · 2024Article
- HIV-1-Infected CD4Journal of immunology (Baltimore, Md. : 1950) · 2022Article
- Regulatory Considerations on the Development of mRNA Vaccines.Current topics in microbiology and immunology · 2022Article
- Article
- Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.Human vaccines & immunotherapeutics · 2014Review
- Article
- Beneficial effects of cathepsin inhibition to prevent chemotherapy-induced intestinal mucositis.Clinical and experimental immunology · 2010Article
- HLA Class II Antigen Presentation in Prostate Cancer Cells: A Novel Approach to Prostate Tumor Immunotherapy.The Open cancer immunology journal · 2010Article
- Salmonella regulates polyubiquitination and surface expression of MHC class II antigens.Proceedings of the National Academy of Sciences of the United States of America · 2009Article
- Proximal glycans outside of the epitopes regulate the presentation of HIV-1 envelope gp120 helper epitopes.Journal of immunology (Baltimore, Md. : 1950) · 2009Article
- Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma.Cancer immunology, immunotherapy : CII · 2008Article
- Phagosome maturation: going through the acid test.Nature reviews. Molecular cell biology · 2008Review
- Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells.Cellular immunology · 2007Article
- Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo.Clinical and experimental immunology · 2006Article
- Components of the antigen processing and presentation pathway revealed by gene expression microarray analysis following B cell antigen receptor (BCR) stimulation.BMC bioinformatics · 2006Article
- The many roads to cross-presentation.The Journal of experimental medicine · 2005Review
- Cathepsin L is essential for onset of autoimmune diabetes in NOD mice.The Journal of clinical investigation · 2005Article
- In vivo immunogenetics: from MIC to RAET1 loci.Immunogenetics · 2003Review
- Invariant chain controls the activity of extracellular cathepsin L.The Journal of experimental medicine · 2002Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.